Intravitreal administration of bevacizumab in the treatment of choroidal metastasis in a patient with erlotinib-failed pulmonary adenocarcinoma

Lung Cancer, 04/10/2012

There was no effective local treatment for saving visual acuity. The off–label use of intravitreal bevacizumab was popular in treating VEGF–mediated chorioretinal diseases worldwide. The authors here demonstrate a dramatic and durable response to intravitreal bevacizumab. Unlike the previous similar reports, the patient had failed both first– and second–line therapies.

Print Article Summary Cat 2 CME Report